Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Corneal Collagen Crosslinking for Progressive Keratoconus and Ectasia Using Riboflavin/Dextran and Hypotonic Riboflavin

NCT01152541 is registered in ClinicalTrials.gov with Cornea and Laser Eye Institute as lead sponsor.

NCT NCT01152541
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01152541 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Corneal Collagen Crosslinking for Progressive Keratoconus and Ectasia Using Riboflavin/Dextran and Hypotonic Riboflavin
Lead sponsor
Cornea and Laser Eye Institute
Phase
Phase 3
Overall status
Unknown status
Start date
June 30, 2010
Completion date
December 31, 2025
Enrollment
160 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

corneal ectasia, keratoconus